Mizuho Sees Strong Risk-Reward in Corbus Pharmaceuticals Holdings, Inc. (CRBP) Near Cash Value
TheFly reported on April 7 that Mizuho raised its price target on CRBP from $39 to $40 while maintaining an Outperform rating.
Corbus Pharmaceuticals Holdings Inc. (CRBP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Cormorant Asset Management Bihua Chen | 2,344,971 | $22,019,278 | 1.11% | |
| 2. | OrbiMed Advisors Samuel Isaly | 1,737,287 | $16,313,125 | +9% | 0.32% |
| 3. | Citadel Investment Group Ken Griffin | 727,060 | $6,827,094 | -14% | 0% |
| 4. | Prosight Capital Lawrence Hawkins | 697,108 | $6,545,844 | +2% | 1.07% |
| 5. | Diadema Partners Timothy Beau Bassett | 439,957 | $4,131,196 | 0.7% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.23 | 25,769 | $572,793.33 | 2,375,000 | 2024-09-20 | Filing | |
| $21.47 | 47,564 | $1,021,389.34 | 2,349,231 | 2024-09-20 | Filing | |
| $20.42 | 139,551 | $2,849,352.32 | 2,301,667 | 2024-09-20 | Filing | |
| $19.61 | 66,088 | $1,296,051.77 | 2,162,116 | 2024-09-20 | Filing | |
| $18.36 | 25,943 | $476,313.48 | 2,096,028 | 2024-09-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.30 | 6,097 | $50,601.44 | 89,790 | 2026-03-02 | Filing | |
| $7.38 | 847 | $6,253.40 | 51,080 | 2026-02-17 | Filing | |
| $7.78 | 4,701 | $36,587.88 | 96,694 | 2026-02-13 | Filing | |
| $7.78 | 13,871 | $107,952.44 | 174,316 | 2026-02-13 | Filing | |
| $8.09 | 3,285 | $26,574.99 | 95,887 | 2026-02-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,321,750 | $12,411,233 | 0.02% | |
| 2. | 734,106 | $6,893,255 | 0% | |
| 3. | 333,415 | $3,130,767 | 0% | |
| 4. | 271,636 | $2,550,662 | 0% | |
| 5. | 187,029 | $1,757,021 | 0% |
News See All
10 Best Biotech Stocks Under $10 to Buy
According to Eli Casdin, CEO of Casdin Capital, biotech is currently experiencing a momentary stop despite being in one of the best economic environments in years.
10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance.
10 Oversold Healthcare Stocks To Invest In
Investing in healthcare stocks during lean economic times is generally regarded as defensive.
7 Best Russell 2000 Stocks to Buy According to Analysts
The investor sentiment remains bullish toward the market, especially since the Fed's recent decision to cut interest rates by half a percentage point, which is seen as a move to sustain economic health...
10 Best Small-Cap Healthcare Stocks To Buy Now
In difficult economic times, healthcare equities are sometimes regarded as a defensive investment.
Oppenheimer's Favorite Stocks For Next 12 Months: Top 32 Stock Picks
The tail end of August is appearing to turn a fresh page for Wall Street.
12 Most Profitable Biotech Stocks To Invest In
In this piece, we will take a look at the 12 most profitable biotech stocks to invest in.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
26 Biggest Marijuana Companies in the World
This article will discuss the 26 biggest marijuana companies in the world, understand some recent industry trends, and navigate the future of the marijuana industry.
Hedge Fund Resource Center